Delivery Order SPE2DB22D3016-SPE2DB25FBAY5
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,462.92 firm fixed-price delivery order is for the supply of GAMUNEX-C 40 GRAM/400 ML VIAL 400 ML medical products. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award, valued at $59,703.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 40 GRAM/400 ML VIAL 400ML, a pharmaceutical product, with a completion date of December 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,125.92 firm-fixed-price delivery order is for the supply of 4566734911 - GAMUNEX-C 20 GRAM/200 ML VIAL 200ML. The contract has an ultimate completion date of January 8, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $55,852.80 firm-fixed-price delivery order contract is for the supply of GAMUNEX-C 40 gram/400 ml vials, with a period of performance through June 30, 2025. The contract is not set aside and was awarded through open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC)...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,731.46 firm fixed-price delivery order is for the medical product "GAMUNEX-C 10 GRAM/100 ML VIAL 100ML" and has an ultimate completion date of January 8, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- This federal contract award, valued at $14,925.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GAMUNEX-C 40 GRAM/400 ML VIAL 400ML, a specialty medication, with a completion date of January 3, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,209.40 firm fixed-price delivery order contract is for the medical product GAMUNEX-C 10 GRAM/100 ML VIAL 100ML. The contract has an ultimate completion date of April 23, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,950.56, is for the provision of the pharmaceutical product GAMUNEX-C 40 GRAM/400 ML VIAL 400ML. The contract has an ultimate completion date of December 26, 2024 and is a firm fixed-price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award, valued at $6,073.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of GAMUNEX-C 5 gram/50 ml vials, a pharmaceutical product. The contract is not set aside and is a firm fixed-price arrangement with a performance period through June 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,109.55 firm fixed-price delivery order contract is for the supply of GAMUNEX-C 10 gram/100 ml vials, a specialty medication, with a completion date of December 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBAY5Delivery Order
This federal contract award, valued at $9,308.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for GAMUNEX-C 40 GRAM/400 ML VIAL 400ML, a pharmaceutical product, with an ultimate completion date of July 24, 2025. The contract is a firm fixed-price arrangement, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.3k | 7/2/25 |